{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:58:29Z","timestamp":1755799109092,"version":"3.44.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Digoxin is primarily used for atrial arrhythmias and known for its narrow therapeutic index. It is predominantly excreted renally and has a long half-life and large volume of distribution, requiring personalized dosing. Due to its narrow therapeutic index, only modestly elevated plasma levels may already cause digoxin toxicity, including gastro-intestinal, ocular, neuropsychiatric, and cardiac complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 66-year-old Caucasian male, with a history of heart failure with preserved ejection fraction and permanent atrial fibrillation, treated with digoxin 0.25\u2005mg daily and metoprolol succinate 200\u2005mg daily presented to the emergency room. He was in cardiogenic shock due to bradycardia resulting from third-degree AV block with varying escape rhythm (minimum of 20\u2005b.p.m.). A temporary external pacemaker lead was placed. Elevated digoxin serum levels (3.2\u20133.4\u2005\u00b5g\/L, toxicity threshold &amp;gt; 2.0\u2005\u00b5g\/L) and hyperkalaemia were found. To reverse digoxin toxicity, digoxin-specific antibody fragments (digoxin-Fabs) were administered and complete recovery of AV-conduction was observed. Interestingly, the patient recently drastically altered his diet and completely abandoned from massive cola and beer intake.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The cause of this intoxication is probably multifactorial, including reduced renal digoxin excretion, co-medication, and most likely changes in diet. We hypothesize that this dietary change not only led to substantial weight loss but also resulted in an increase of intragastric pH, thereby significantly enhancing digoxin uptake. This case underscores the importance of considering digoxin-Fabs treatment based on several factors including clinical presentation and digoxin serum levels. Furthermore, it highlights the importance of regular lifestyle anamnesis and renal function assessment to reassess digoxin dosage.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaf352","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:20:42Z","timestamp":1755620442000},"source":"Crossref","is-referenced-by-count":0,"title":["Dietary lifestyle changes unexpectedly causing digoxin intoxication with cardiogenic shock: a grand round case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3386-9974","authenticated-orcid":false,"given":"Anna M","family":"Gerritsma","sequence":"first","affiliation":[{"name":"Department of Cardiology, Diakonessenhuis , Bosboomstraat 1, 3582 KE Utrecht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quint A J","family":"Hagdorn","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Diakonessenhuis , Bosboomstraat 1, 3582 KE Utrecht ,","place":["The Netherlands"]},{"name":"Department of Cardiology, University Medical Center Utrecht, Utrecht University , Heidelberglaan 100, 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timon H","family":"Geurkink","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Diakonessenhuis , Bosboomstraat 1, 3582 KE Utrecht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G","family":"Groothuis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Diakonessenhuis , Bosboomstraat 1, 3582 KE Utrecht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara E E","family":"van Ofwegen-Hanekamp","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Diakonessenhuis , Bosboomstraat 1, 3582 KE Utrecht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8474-5637","authenticated-orcid":false,"given":"Jurjen S","family":"Lagas","sequence":"additional","affiliation":[{"name":"Department of Pharmacy & Pharmacology, Diakonessenhuis , Bosboomstraat 1, 3582 KE Utrecht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"2025081912203608900_ytaf352-B1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MEJ.0000000000001065","article-title":"Diagnosis and practical management of digoxin toxicity: a narrative review and consensus","volume":"30","author":"Andrews","year":"2023","journal-title":"Eur J Emerg Med"},{"key":"2025081912203608900_ytaf352-B2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ajoc.2018.02.024","article-title":"Colored floaters as a manifestation of digoxin toxicity","volume":"10","author":"Shi","year":"2018","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2025081912203608900_ytaf352-B3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12471-023-01814-y","article-title":"Digoxin-specific antibodies: a novel dosing strategy","volume":"32","author":"Dijkman","year":"2024","journal-title":"Neth Heart J"},{"key":"2025081912203608900_ytaf352-B4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2025081912203608900_ytaf352-B5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCHEARTFAILURE.113.000784","article-title":"Emergency department visits and hospitalizations for digoxin toxicity United States, 2005 to 2010","volume":"7","author":"See","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2025081912203608900_ytaf352-B6","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology foundation\/American Heart Association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025081912203608900_ytaf352-B7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.amjopharm.2010.10.001","article-title":"Use of digoxin for heart failure and atrial fibrillation in elderly patients","volume":"8","author":"Cheng","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"key":"2025081912203608900_ytaf352-B8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40262-023-01320-9","article-title":"Digoxin pharmacokinetics in patients with obesity before and after a gastric bypass or a strict diet compared with normal weight individuals","volume":"63","author":"Kvitne","year":"2024","journal-title":"Clin Pharmacokinet"},{"key":"2025081912203608900_ytaf352-B9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/phar.1560","article-title":"Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substrates","volume":"35","author":"Chan","year":"2015","journal-title":"Pharmacotherapy"},{"key":"2025081912203608900_ytaf352-B10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1365-2036.2009.03993.x","article-title":"Systematic review: impaired drug absorption related to the co-administration of antisecretory therapy","volume":"29","author":"Lahner","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"2025081912203608900_ytaf352-B11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/gut.34.6.843","article-title":"Alcohol and gastric acid secretion in humans","volume":"34","author":"Chari","year":"1993","journal-title":"Gut"},{"key":"2025081912203608900_ytaf352-B12","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans","volume":"365","author":"Budnitz","year":"2011","journal-title":"N Engl J Med"},{"key":"2025081912203608900_ytaf352-B13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.amjcard.2022.08.004","article-title":"Characteristics and outcomes of suspected digoxin toxicity and immune fab treatment over the past two decades\u20142000\u20132020","volume":"183","author":"Peters","year":"2022","journal-title":"Am J Cardiol"},{"key":"2025081912203608900_ytaf352-B14","doi-asserted-by":"crossref","first-page":"103400","DOI":"10.1016\/j.etap.2020.103400","article-title":"Digoxin: pharmacology and toxicology\u2014a review","volume":"79","author":"Patocka","year":"2020","journal-title":"Environ Toxicol Pharmacol"},{"key":"2025081912203608900_ytaf352-B15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.amjmed.2024.08.018","article-title":"Expert consensus on the diagnosis and management of digoxin toxicity","volume":"138","author":"Hack","year":"2025","journal-title":"Am J Med"},{"key":"2025081912203608900_ytaf352-B16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3109\/15563650.2014.943907","article-title":"Digoxin-specific antibody fragments in the treatment of digoxin toxicity","volume":"52","author":"Chan","year":"2014","journal-title":"Clin Toxicol"},{"key":"2025081912203608900_ytaf352-B17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00003088-199528060-00006","article-title":"Pharmacokinetic aspects of digoxin-specific fab therapy in the management of Digitalis toxicity","volume":"28","author":"Ujhelyi","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"2025081912203608900_ytaf352-B18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2165\/00002018-200427140-00004","article-title":"Fab antibody fragments","volume":"27","author":"Flanagan","year":"2004","journal-title":"Drug Saf"},{"key":"2025081912203608900_ytaf352-B19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/15563650.2018.1546010","article-title":"Clinical outcomes from early use of digoxin-specific antibodies versus observation in chronic digoxin poisoning (ATOM-4)","volume":"57","author":"Chan","year":"2019","journal-title":"Clin Toxicol"},{"key":"2025081912203608900_ytaf352-B20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/11590340-000000000-00000","article-title":"Prognostic utility of serum potassium in chronic digoxin toxicity: a case\u2013control study","volume":"11","author":"Manini","year":"2011","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/8\/ytaf352\/64084482\/ytaf352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/8\/ytaf352\/64084482\/ytaf352.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:20:45Z","timestamp":1755620445000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytaf352\/8238123"}},"subtitle":[],"editor":[{"given":"Fabian","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Laura","family":"Rottner","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Henrike Aenne Katrin","family":"Hillmann","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Niklas","family":"Schenker","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaf352","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,8,1]]},"article-number":"ytaf352"}}